Table 1.

Characteristics of study samples

Sample numberHIV-1 statusAgeGenderARV useDrug abuseCNS pathologiesNeurocognitive diagnosisCSF VL (copies/ml)
1+34FYNoneHypoxic/ischemic damageHAD76
2+57MNNoneAtherosclerosis of the brainHAD2747
3+53MYNoneNAHAD50
4+40MNNoneNAHAD400
5+34MYNAMinimal abnormalitiesHADNA
6+34MNNoneMinimal abnormalitiesHADNA
7+40MNNAMinimal abnormalitiesHADNA
8+35MYNAMinimal abnormalitiesHADNA
9+30MYNoneMicroglial nodule encephalitisCMV encephalitis9627
10+43FYPast cocaine, opiateBacterial parenchymal infection, contusionNeuropsychological impairment due to other causes50
11+61MNANACMV encephalitis, Optic nerve atrophyNeuropsychological impairment due to other causes2617
12+46FYCocaineNo known pathologyNeuropsychological impairment due to other causes27400
13+35MYNACMV encephalitis, aseptic leptomeningitisNeuropsychological impairment due to other causes50
14+49MYNoneCMV encephalitis, microglial nodule encephalitisNeuropsychological impairment due to other causes841
15+44MYPast cocaineCMV encephalitis, focal infarct, HIVENeuropsychological impairment due to other causes100000
16+46MYPast cocaineNo known pathologyNeurocognitive normal2355
17+45MYNoneFocal infarct, contusionNeurocognitive normal11405
18+51MNAPast cocaineBacterial parenchymal infectionNeurocognitive normal53215
19+37MYNACryptococcusNeurocognitive normal400
20+47MYNoneOther noninfectious pathNeurocognitive normalNA
21+34FYNAOther noninfectious pathNeurocognitive normal50
22+39MYNAMinimal abnormalitiesNeurocognitive normalNA
2318MNoneNoneNANeurocognitive normalNone
2437MNoneNoneNANeurocognitive normalNone
2552MNoneNoneNANeurocognitive normalNone
  • F, Female; M, male; Y, yes; N, no; NA, not available; CMV, cytomegalovirus; VL, viral load; ARV, antiretroviral; HIVE, HIV encephalitis.